Background {#sec1-2048004017705273}
==========

The worldwide incidence of chronic kidney disease (CKD) has been sharply increasing over the recent decades. In developing countries where there is cohabitation of a double burden of infectious and non-communicable diseases \[[@bibr1-2048004017705273]\], CKD constitutes a significantly more important challenge for health systems than elsewhere \[[@bibr2-2048004017705273],[@bibr3-2048004017705273]\]. Morbidities and mortalities arising from CKD in these areas are enormous and related to limited access to treatment options \[[@bibr4-2048004017705273]\].

Currently, renal replacement therapy (either maintenance hemodialysis (HD) or peritoneal dialysis) has been widely adopted as the mainstay of care for patients with end-stage CKD \[[@bibr5-2048004017705273]\]. Dialysis prolongs survival, reduces morbidities, and improves patients' quality of life. However, these patients are at an elevated risk of cardiovascular disease (CVD) \[[@bibr6-2048004017705273][@bibr7-2048004017705273]--[@bibr8-2048004017705273]\]. Indeed, CVD is the leading cause of deaths in this category of patients; it accounts for almost 40--50% of all-cause mortality, a rate 10 to 30 fold higher than in the general population \[[@bibr9-2048004017705273][@bibr10-2048004017705273]--[@bibr11-2048004017705273]\]. This risk is even greater for young dialysis patients \[[@bibr12-2048004017705273]\].

Evidence has accumulated a number of risk factors for CVD in dialysis patients among which are older age, hypertension, diabetes mellitus (DM), vascular calcification, inflammation, increased visceral fat level, dyslipidemias, high serum uric acid levels, and lower calcium levels \[[@bibr6-2048004017705273],[@bibr13-2048004017705273][@bibr14-2048004017705273][@bibr15-2048004017705273][@bibr16-2048004017705273]--[@bibr17-2048004017705273]\].

These risk factors may vary from one population to another; they should be identified and addressed in an attempt to mitigate the burden of CVD in dialysis patients. Some studies have evaluated the global risk of CVD in people living in sub-Saharan Africa (SSA) \[[@bibr18-2048004017705273],[@bibr19-2048004017705273]\], but very few have been carried-out among patients on maintenance HD. This study was thus designed, willing to assess the risk of CVD among a group of patients undergoing maintenance HD in Cameroon (a SSA country) and to identify potential factors likely to impact this risk.

Methods {#sec2-2048004017705273}
=======

Ethical statement {#sec3-2048004017705273}
-----------------

Before starting this study, an ethical clearance was delivered by the Ethical Review Board of the Catholic University of Central Africa based in Yaoundé, Cameroon (Number 0132/2016), and an authorization was obtained from the administrative authorities of the Yaoundé University Teaching Hospital. All the procedures used in this study concurred with the current revision of the Helsinki Declaration. All aspects in relation with the study were fully presented and explained to each participant, and we enrolled only those who volunteered to participate; they signed the consent form in this respect. Refusal to be included did not expose the person to any management prejudice. Results of patients were sent to their physicians for better care. In addition, participants were educated and sensitized on the huge benefits of healthy diets and regular physical activity.

Study design, setting, and participants {#sec4-2048004017705273}
---------------------------------------

In January 2016, we carried-out a cross-sectional study at the Yaoundé University Teaching Hospital, which is located in Yaoundé, the capital city of Cameroon. This is a tertiary reference hospital including a dialysis unit with nearly 70 patients being regularly dialyzed 2 to 3 times per week with each session lasting for 4 h.

Participants were end-stage CKD patients, aged 20 years and above, who have been dialyzing for at least 3 months in the unit, and who voluntarily accepted to be included in the study. Patients on transit in Yaoundé and coming to be dialyzed in the unit were not included in this study.

Data collection {#sec5-2048004017705273}
---------------

A structured, auto-administered, and pre-tested questionnaire served for data collection, which comprised socio-demographic characteristics (age, sex, religion, marital status, level of education, ethnic origin, and profession), medical history (past medical events, family history of diabetes, hypertension, or other relevant disease), and lifestyle habits (physical exercise, smoking, consumption of alcohol, and consumption of fruits and vegetables). No amendments were brought to the questionnaire following pre-testing. Thereafter, we conducted a physical examination during which blood pressure (composite of systolic blood pressure (SBP) and diastolic blood pressure (DBP) in mmHg), body dry weight, and height (respectively to the nearest kilogram and centimeter) were measured. Body mass index (BMI) was then derived as weight (kg)/height^2^ (m^2^). Subsequently, we agreed on an appointment for blood collection.

Blood collection and biochemical assays {#sec6-2048004017705273}
---------------------------------------

Blood was aseptically collected after a 12-h overnight fasting and before dialysis, then put on ice and immediately transported to the biochemistry laboratory where plasma or serum specimens were separated by centrifugation at 3000 rpm within 5 min for analyses without delay. Biochemical assays included fasting plasma glucose (FPG), total cholesterol (TC), triglycerides (TG), high-density lipoproteins cholesterol (HDL-C), urea, and creatinine. Low-density lipoproteins cholesterol (LDL-C) was calculated using Friedwald's formula \[[@bibr20-2048004017705273]\]. The GFR was determined using the MDRD formula, which takes into account the age (years), sex (male/female), weight (kg), creatinemia (µmol/l), and ethnicity (African origin or not) \[[@bibr21-2048004017705273]\]. We used an electronic calculator for this process, on this webpage: "<http://publication.radioanatomie.com/002_manipulateurs/calcul-de-la-clairance-de-la-creatinine.php>."

Calculation and stratification of the cardiovascular risk (CVR) {#sec7-2048004017705273}
---------------------------------------------------------------

We used the Framingham risk score (FRS) to assess the 10-year risk of cardiovascular events. It was electronically derived on this web page "<https://www.cvdriskchecksecure.com/FraminghamRiskScore.aspx>," based on the following parameters: age (years), sex (male/female), diabetes (yes/no), smoking (yes/no), BP lowering medications (yes/no), SBP (mmHg), TC (mmol/l), and HDL-C (mmol/l). The FRS is a predictor of the 10-year risk of developing a coronary event (composite of myocardial infarction and coronary death), and is considered a standard and generally acceptable approach to risk prediction \[[@bibr22-2048004017705273]\]. Participants were subsequently grouped into three classes, given they presented a low risk (score \< 10%), a moderate risk (score 10--20%), or a high risk of CVD (score \> 20%) \[[@bibr23-2048004017705273]\].

Statistical analyses {#sec8-2048004017705273}
--------------------

Data were coded, entered, and analyzed using SPSS version 20.0 (IBM SPSS Inc., Chicago, Illinois, USA). Results are presented as frequency (percentage) for qualitative variables, and median (interquartile range (IQR)) for quantitative ones. Qualitative variable comparisons used the Chi-square test or Fisher exact test, and that of quantitative variables, the Mann--Whitney U test. The Spearman correlation test served to search for any relation between the CVR and other parameters, completed by univariable and multivariable linear regression analyses. We introduced in the multivariable model all variables with a p value \<0.25 in univariable analyses, and used a backward selection process. Results were considered statistically significant if p \< 0.05.

Results {#sec9-2048004017705273}
=======

Of the 70 chronic hemodialyzed patients, 44 (62.9%) accepted to take part in this study. The male/female sex ratio was 3/1 ([Table 1](#table1-2048004017705273){ref-type="table"}). Ages ranged from 31 to 80 years, with a median of 55 (40--62) years ([Table 2](#table2-2048004017705273){ref-type="table"}). The majority of participants were married (76.5%) and of Catholic religion (56.8%) ([Table 1](#table1-2048004017705273){ref-type="table"}). The distributions of age and sex were similar between respondents and non-respondents: median age 55 vs. 53 years (p = 0.258); male proportion 75% vs 78% (p = 0.530). Table 1.Characteristics of the study population.VariableNumberPercentage (%)Sex Male3375.0 Female1125.0Marital status Single511.4 Married3170.5 Widow(ed)613.6 Divorced24.5Religion Catholic2556.8 Protestant1125.0 Muslim715.9 Animist12.3Level of education Primary school920.5 Secondary school1125.0 University/college1738.6 Never went to school715.9Ethnic origin Bassa36.8 Bulu36.8 Bamiléké1840.9 Ewondo613.6 Toupouri12.3 Others1329.5Hypertension Yes2659.1 No1840.9Diabetes Yes511.4 No3988.6Smoking Yes24.5 No4295.5Alcohol consumption Yes511.4 No3988.6Practice of physical activity Yes2352.3 No2147.7Number of physical activity sessions \<3 per week3272.7 ≥3 per week1227.3Cardiovascular risk Low2045.5 Moderate1022.7 Severe1431.8 Table 2.Results of anthropometric and biochemical variables.VariableMin--MaxMedian (IQR)Age (years)31--8055 (40--62)Number of physical activity sessions per week0--70.5 (0--3)Duration on dialysis (months)3--14613 (6.25--64.5)Weight (kg)49--9971.0 (66.25--81.65)Height (m)1.54--1.951.69 (1.65--1.76)Body mass index (kg/m^2^)16.57--31.8924.83 (23.10--28.34)Systolic blood pressure (mmHg)98--206137.5 (121.5--163.5)Diastolic blood pressure (mmHg)51--14472.5 (64.25--83.26)Glycemia (g/l)0.52--5.211.09 (0.90--1.23)Total cholesterol (mg/dl)27--210134 (123--148)HDL cholesterol (mg/dl)13--9040 (28--48)LDL cholesterol (mg/dl)13--24976 (60--88)Triglycerides (mg/dl)47--253101 (79--143)Serum urea (g/l)0.8--6.071.90 (1.41--2.76)Creatinemia (mg/l)45.53--228.71133.31 (90.04--179.65)Glomerular filtration rate (ml/min)2.70--17.105.10 (3.70--6.48)Framingham risk score (%)\<1--\>3012.25 (4.93--24.38)[^1]

We found 26 hypertensive patients (59.1%), 5 with DM (11.4%), and only two current smokers (4.5%). Twenty-three patients (52.3%) were practicing a regular physical activity, with only 12 (52.2%) having at least three sessions per week ([Table 1](#table1-2048004017705273){ref-type="table"}). The number of sessions ranged from 0 to 7 with a median of 0.5 (0--3) sessions per week ([Table 2](#table2-2048004017705273){ref-type="table"}). Median values of BMI, SBP, DBP, FPG, TC, LDL-C, HDL-C, TG, serum urea, serum creatinine, and GFR are presented in [Table 2](#table2-2048004017705273){ref-type="table"}. The average duration on dialysis varied between 3 and 146 months with a median of 13 (6.3--64.5) months ([Table 2](#table2-2048004017705273){ref-type="table"}). The CVR estimated by the FRS ranged from less than 1% to more than 30% with a median of 12.3% (4.9--24.4) ([Table 2](#table2-2048004017705273){ref-type="table"}). Twenty dialyzed patients (45.5%) had a low risk of CVD, 10 (22.7%) a moderate risk, and 14 (31.8%) presented a high risk of CVD ([Table 1](#table1-2048004017705273){ref-type="table"}).

[Table 3](#table3-2048004017705273){ref-type="table"} depicts the correlation between CVR and other variables. Only two variables were significantly correlated with CVR: duration on dialysis (ρ = 0.454; p = 0.002) and number of physical activity sessions per week (ρ = −0.527; p \< 0.0001). The other correlations were weak and statistically non-significant ([Table 3](#table3-2048004017705273){ref-type="table"}). Furthermore, in univariable linear regression analyses ([Table 4](#table4-2048004017705273){ref-type="table"}), three parameters significantly impacted the CVR: duration on dialysis (β = 0.10; 95% confidence interval (CI): 0.02, 2.18; p = 0.013), number of physical activity sessions per week (β = −2.15; 95% CI: −3.33, −0.97; p = 0.001), and serum TG levels (β = 6.46; 95% CI: 0.15, 12.78; p = 0.045). All variables with p \< 0.25 in univariable analyses were introduced in the multivariable model. In the final model after a backward selection process, we found that duration on dialysis (adjusted β = 0.11; 95% CI: 0.04, 0.17; p = 0.003), number of physical activity sessions per week (adjusted β = −1.35; 95% CI: −2.45, −0.25; p = 0.018), FPG levels (adjusted β = 4.22; 95% CI: 0.65, 7.78; p = 0.022), serum TG levels (adjusted β = 5.94; 95% CI: 0.51, 11.38; p = 0.033), and serum urea levels (adjusted β = −2.08; 95% CI: −4.04, −0.11; p = 0.039) independently influenced our patients' CVR. The coefficient of determination for this final model was 0.44 ([Table 4](#table4-2048004017705273){ref-type="table"}). Table 3.Correlation between cardiovascular risk and other parameters.VariableCoefficient of correlation (ρ)p valueDuration on dialysis0.454**0.002** [\*](#table-fn4-2048004017705273){ref-type="table-fn"}Number of physical activity sessions per week−0.527**\<0.0001**\*Body mass index−0.0260.868Glycemia0.0660.671Diastolic blood pressure0.0490.755LDL cholesterol0.1090.480Triglycerides0.2610.087Serum urea−0.1730.260Creatinemia−0.1100.478[^2] Table 4.Univariable and multivariable linear regression analyses.Variableβ (95% CI)p valueAdjusted β (95% CI)^[a](#table-fn5-2048004017705273){ref-type="table-fn"}^p valueDuration on dialysis (months)**0.10 (0.02, 2.18)0.013** **^[b](#table-fn6-2048004017705273){ref-type="table-fn"}^** [\*](#table-fn7-2048004017705273){ref-type="table-fn"}**0.11 (0.04, 0.17)0.003** [\*](#table-fn7-2048004017705273){ref-type="table-fn"}Number of physical activity sessions per week**−2.15 (−3.33, −0.97)0.001** **^[b](#table-fn6-2048004017705273){ref-type="table-fn"}^** [\*](#table-fn7-2048004017705273){ref-type="table-fn"}**−1.35 (−2.45, −0.25)0.018** [\*](#table-fn7-2048004017705273){ref-type="table-fn"}Body mass index (kg/m^2^)−0.15 (−0.96, 0.66)0.714/Glycemia (g/l)3.80 (−0.65, 8.25)0.092^[b](#table-fn6-2048004017705273){ref-type="table-fn"}^**4.22 (0.65, 7.78)0.022** [\*](#table-fn7-2048004017705273){ref-type="table-fn"}Diastolic blood pressure (mmHg)−0.02 (−0.19, 0.15)0.773//LDL cholesterol (g/l)5.18 (−2.87, 13.24)0.201^[b](#table-fn6-2048004017705273){ref-type="table-fn"}^//Triglycerides (g/l)**6.46 (0.15, 12.78)0.045** **^[b](#table-fn6-2048004017705273){ref-type="table-fn"}^** [\*](#table-fn7-2048004017705273){ref-type="table-fn"}**5.94 (0.51, 11.38)0.033** [\*](#table-fn7-2048004017705273){ref-type="table-fn"}Serum urea (g/l)−1.83 (−4.33, 0.67)0.147^[b](#table-fn6-2048004017705273){ref-type="table-fn"}^**−2.08 (−4.04, −0.11)0.039** [\*](#table-fn7-2048004017705273){ref-type="table-fn"}Creatinemia (mg/l)−0.04 (−0.10, 0.03)0.254//[^3][^4][^5][^6]

Discussion {#sec10-2048004017705273}
==========

Our results showed 54.5% of the study population presenting a moderate or high risk of CVD. Besides, longer duration on dialysis, lower number of weekly physical activity sessions, higher levels of FPG, higher titers of serum TGs, and lower levels of serum urea before dialysis seemed to significantly increase dialyzed patients' risk of CVD. Therefore, it can be inferred from these results that healthy lifestyle habits (healthy diet, regular physical activity) may substantially contribute in curtailing the current or future burden of CVD among our patients on HD.

The study design added to this small sample size precludes us from claiming that the factors we have raised are real independent risk factors significantly influencing our patients' risk of CVD. Our response rate was low; the non-respondents claimed having been used to taking part in such studies, but have never received their results back before, justifying thus their anger and refusal to be enrolled anymore, despite all explanations and convincing attempts by the research team. We were incapable of increasing the sample size, being limited by financial constraints as the study benefited from no funding. Larger and better designed studies are warranted to better assess the global risk of CVD among HD patients and identify all associated risk factors in our context. In the absence of locally developed tools to assess the risk of CVD, we used the FRS which may lack to accurately assess the CVR in African populations as they may present different patterns of CVD as compared with Western countries \[[@bibr24-2048004017705273]\]. Furthermore, the FRS was developed for the general population rather than for HD patients; therefore, it can underestimate the CVR. Moreover, the hospital-based and unique recruitment site natures of this study hinder perhaps the generalizability of our results to the entire HD population of the country.

Nonetheless and to the best of our knowledge, this is the first study in Cameroon and the Central-African Region dedicated to assessing the risk of CVD in HD patients and related influencing factors. We used strong and rigorous statistical procedures to analyze our data. Our results give an insight into the picture of risk of CVD in Cameroonian HD patients, which could be translatable to other SSA countries; they constitute the starting point for further researches in the region and can be used to improve HD patients' management.

This study showed that longer duration on dialysis is likely to augment the risk of CVD. Indeed, it was observed that each new month spent in dialysis could lead to a 0.11% increment in the risk of CVD. On the contrary and intriguingly, we found that a 1 g/l rise in the serum urea levels before dialysis would be accompanied by a 2.1% reduction in the risk of CVD, whereas we were expecting the inverse to occur. The small sample size of this study alongside its design could explain these results, though we need longitudinal data to better elucidate this point.

This study consolidates existing evidence that physical activity is a paramount contributor for CVD prevention. Indeed, we learn from this study that each one-increase in the number of physical activity sessions per week could result in a 1.35% reduction in the risk of CVD. People who are physically inactive have an incremental risk of all-cause mortality in comparison to those who have at least 150 min of moderate-intensity physical activity per week, or equivalent, as recommended by World Health Organization (WHO) \[[@bibr25-2048004017705273]\]. Regrettably, SSA countries are currently going through an epidemiological transition, and rapid urbanization with decrease in physical activity levels or increase in sedentary lifestyle seems to play an important role in this transition \[[@bibr26-2048004017705273][@bibr27-2048004017705273]--[@bibr28-2048004017705273]\]. It is therefore high time strong measures be taken by local Governments to promote physical activity in SSA.

This study confirms the influence of FPG levels on the risk of CVD \[[@bibr18-2048004017705273],[@bibr19-2048004017705273],[@bibr29-2048004017705273]\]. There is body of evidence demonstrating that DM is a known risk factor for CVD. It has been shown indeed that those individuals with diabetes have a 2 - to 4-fold augmented risk of developing cardiovascular events than their counterparts of the same age and sex without diabetes \[[@bibr29-2048004017705273]\]. Likewise, people with prediabetes, a precursor to DM also have an increased risk of developing CVD \[[@bibr30-2048004017705273]\]. We believe that HD patients should be screened for prediabetes or DM and adequate measures taken to prevent progression to DM or delay the onset of DM complications.

Moreover, dyslipidemia, which is defined as elevated levels of serum TC and/or TGs, is a well-established traditional risk factor for atherosclerotic coronary artery disease in the general population and more so in patients with CKD \[[@bibr13-2048004017705273]\]. In fact, findings from the present study indicate that each 1 g/l increment in serum TGs titers would lead to a 5.94% augmentation in the risk of CVD. Treatment of dyslipidemia with lipid-lowering medications is considered a plausible strategy for reducing CVD in dialysis patients, but this is not to be done on a systematic basis \[[@bibr13-2048004017705273]\]. We need studies in SSA to underpin such a recommendation with strong local evidences.

Conclusion {#sec11-2048004017705273}
==========

Around 55% of our hemodialyzed study population presented a moderate or high risk of CVD. Duration on dialysis, number of physical activity sessions per week, FPG, serum TGs, and serum urea levels may impact our HD patients' risk of CVD. Accordingly, they should be encouraged to adopt healthy lifestyles including healthy diets and the practice of a regular moderate-to-vigorous physical activity. Additionally, lipid-lowering medications could be discussed in case of dyslipidemia. Notwithstanding, we need further studies to better characterize the risk of CVD and influencing factors among SSA patients suffering from end-stage CKD and undergoing maintenance HD.
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[^1]: IQR: interquartile range; HDL: high-density lipoproteins; LDL: low-density lipoproteins; Max: maximum; Min: minimum.

[^2]: p value \<0.05. Bold values in these tables represent those with a p value less than 0.05.

[^3]: Using a backward selection process, LDL cholesterol was removed from the first model; here are presented results of the second (final) model, with R^2 ^= 0.502, adjusted R^2 ^= 0.441; p \< 0.0001.

[^4]: All these variables had a p \< 0.25 in univariable analyses and were thus introduced in the initial multivariable model.

[^5]: p \< 0.05.

[^6]: CI: confidence interval. Bold values are significant results, that is those with a p value less than 0.05.
